サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：次世代シーケンスキット市場- 世界の産業規模、シェア、動向、機会、および予測、2018-2028年
市場調査レポート
商品コード
1342716

次世代シーケンスキット市場- 世界の産業規模、シェア、動向、機会、および予測、2018-2028年

Next Generation Sequencing Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Workflow, By Sequencing Type, By Usage Area, By Application, By End User, By Region and Competition

出版日
ページ情報
英文 111 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

次世代シーケンスキット市場- 世界の産業規模、シェア、動向、機会、および予測、2018-2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 111 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

次世代シーケンシングキット市場は、予測期間中に目覚ましい成長を遂げると予測されています。

これは、iSeq 100システムやIon Gene Studio S5を使用した、より優れた検査技術など、NGSプラットフォームの進歩が世界中で進んでいるためと考えられます。同様に、NGSベースの診断検査に対する規制や償還のシナリオが改善されつつあることも、長年にわたる市場の成長をさらに促進するものと思われます。さらに、がんの有病率の増加と、がんおよびその他の感染症研究における次世代シーケンサーの応用の増加は、予測期間中に大きな成長を生み出すと予想されます。さらに、ポータブルシーケンステクノロジーの開拓が進むとともに、主要な主要企業や研究機関とのNGSの技術的進歩に向けた提携や共同研究が活発化していることも、予測期間中の市場の成長を促進すると予想されます。

NGSにおける進歩の高まり

嚢胞性線維症や鎌状赤血球症のような希少遺伝性疾患の診断のためのDNA検査に対する需要の高まりは、ここ数年で著しく増加しています。さらに、より少ないコストでより迅速な結果を提供できる高度な技術に対する需要の高まりが、予測期間中の次世代シーケンシングキットの世界市場の成長を促進すると予想されます。

慢性疾患の早期発見に対する需要の高まり

がんやその他の感染症の早期治療を成功させるためには、NGS技術が必要です。そのため、がんや結核、髄膜炎菌性疾患などの他の感染症の有病率の増加は、予測期間中にNGSキット市場の成長を促進すると予想される主要な要因の1つです。例えば、2022年2月に世界保健機関（WHO）が提供したデータによると、がんは世界の主要死因であり、2020年には約1,000万人の死亡を占めています。そのため、臨床微生物学における分子診断法の利用は近年急速に増加しています。次世代シーケンサー（NGS）のような分子診断技術は、核酸の存在を検出することができ、この技術は迅速で、培養で検体を増殖させる必要がないです。研究者は次世代シーケンシングのテキストを使用することで、サンプルから異なる疾患を同時かつ直接検出することができます。さらに、マイクロアレイのような伝統的な技術をNGS技術に置き換えて迅速に検出することで、NGSキットの需要は今後さらに高まると思われます。例えば、2022年1月、Illumina Inc.とVanderbilt University Medical Center（VUMC）の完全子会社であるNashville Biosciences LLCは、イルミナの次世代シーケンサー（NGS）プラットフォームを用いた大規模ゲノム解析と卓越した臨床ゲノムリソースの確立により医薬品開発を加速するための複数年契約を締結しました。

利用可能なカスタマイズ

TechSci Researchは、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 次世代シーケンスキットの世界市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • ワークフロー別（ライブラリー調製、クラスタージェネレーション、シーケンス試薬キット）
    • シーケンスタイプ別（WESおよびWGS、ターゲットシーケンス、ロングリードシーケンス、その他のシーケンス）
    • 使用領域別（臨床、調査）
    • 用途別（腫瘍、希少疾患、遺伝子疾患、生殖医療、その他）
    • エンドユーザー別（学術・研究機関、製薬・バイオテクノロジー企業、臨床・診断ラボ、その他）
    • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
    • 企業別（2022年）
  • 市場マップ
    • ワークフロー別
    • シーケンスタイプ別
    • 使用領域別
    • アプリケーション別
    • エンドユーザー別
    • 地域別

第6章 北米の次世代シーケンスキット市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • ワークフロー別
    • シーケンスタイプ別
    • 使用領域別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の次世代シーケンスキット市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア＆予測
    • ワークフロー別
    • シーケンスタイプ別
    • 使用領域別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の次世代シーケンスキット市場展望

  • 市場規模および予測
    • 金額別
  • 市場シェア＆予測
    • ワークフロー別
    • シーケンスタイプ別
    • 使用領域別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の次世代シーケンスキット市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • ワークフロー別
    • シーケンスタイプ別
    • 使用領域別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの次世代シーケンスキット市場展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • ワークフロー別
    • シーケンスタイプ別
    • 使用領域別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
    • NGSの進展
    • 慢性疾患の早期発見に対する需要の高まり
  • 課題
    • 熟練した専門家とインフラの不足
    • 厳しい規制

第12章 市場動向と発展

  • 最近の発展
  • 合併と買収
  • 製品上市

第13章 次世代シーケンスキットの世界市場SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • BGI Group.
    • Creative Biogene
    • Danaher.
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Illumina, Inc.
    • Oxford Nanopore Technologies plc.
    • Pacific Biosciences of California, Inc.
    • PerkinElmer Inc.

第16章 戦略的提言

目次
Product Code: 14801

Next Generation Sequencing Kits market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising advancements NGS platform such as using the iSeq 100 system and Ion Gene Studio S5 in the technology for better testing across the globe. Similarly, the growing improvement of regulatory and reimbursement scenarios for NGS-based diagnostics tests will further drive the growth of the market over the years. Additionally, the growing prevalence of cancer and increasing applications of next-generation sequencing in cancer and other infectious diseases research is expected to create significant growth during the forecasted period. Moreover, the growing development of portable sequencing technologies along with growing partnerships & collaborations for technological advancements in NGS with major key players and research institutes is expected to drive the growth of the market during the forecast period.

Growing Advancements in NGS

Growing demand for DNA testing for the diagnosis of some rare genetic diseases such as cystic fibrosis and sickle cell diseases has significantly increased over the years. Additionally, the growing demand for advanced technology which can provide faster results at less cost is expected to drive the growth of global next generation sequencing kits market during the forecast period.

For instance, in January 2022, a new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators used to diagnose rare genetic diseases in an average of eight hours. Genome sequencing helps scientists to find a patient's complete DNA makeup which contains information about everything from eye color to inherited diseases and it is vital for diagnosing patients with diseases rooted in their DNA. Also, the growing genome mapping program linked to different types of diseases and understanding inherited disorders and their treatment will further drive the growth of the market during the forecast period. Public, private, and non-profit interests have also invested largely in the technology to treat novel diseases and improve diagnostics and healthcare. Increased availability of funding supported by the next-generation sequencing market will further enhance the demand for the NGS kits market during the forecast period.

Growing Demand for Early Detection of Chronic Diseases

For the successful treatment of cancer and other infectious diseases in the early stage, NGS technology is required. So, the growing prevalence of cancer and other infectious diseases such as tuberculosis, meningococcal diseases, etc is one of the major factors expected to drive the growth of the NGS kits market during the forecast period. For instance, according to the data provided by World Health Organization (WHO) in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. So, the usage of molecular diagnostics methods in clinical microbiology has increased rapidly in recent years. Molecular diagnostic technologies such as next-generation sequencing (NGS) can detect the presence of nucleic acids and this technology are quick and doesn't require specimen growth in culture. The researchers can use next-generation sequencing texts to detect different diseases concurrently and directly from a sample. Additionally, replacing the traditional technologies such as microarrays by NGS technology for fast detection will further enhance the demand for NGS kits over the years. For instance, in January 2022, Illumina Inc. and Nashville Biosciences LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), entered a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinical-genomic resource using Illumina's next-generation sequencing (NGS) platforms.

Market Segmentation

Global Next Generation Sequencing Kits market can be segmented on the basis of workflow, sequencing type, usage area, application, end users and by region. Based on the workflow, the market is further segmented into library preparation, cluster generation, and sequencing reagents kits. Based on sequencing type, the market can be segmented into WES and WGS, targeted sequencing, long read sequencing, and other sequencing. Based on the usage area, the market can be bifurcated into clinical and research. Based on application, the market can be further grouped into oncology, rare diseases, genetic disorders, reproductive health, and others. Based on end users, the market can be grouped into academic and research institutions, pharmaceutical and biotechnology companies, clinical, diagnostic laboratories, and others. Regionally, in terms of region North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. On the basis of country, the United States dominated the global next generation sequencing kits market on account of the increasing demand for early detection of infectious diseases in the country.

Recent Development

  • In January 2021, BGI group received the CE mark approval for the Thalassemia Gene Detection Kit which will be used for the genetic diagnosis of thalassemia and other hemoglobinopathy or for general population carrier screening.
  • In September 2020, Themo Fisher Scientific received the US FDA premarket approval for the Oncomine Dx Target Test as and NGS based companion diagnostic test to identify RET fusion positive, metastatic non-small cell lung cancer patients receiving GAVRETO which is a targeted therapy developed by Blueprint Medicines.

Market Players

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI Group., Creative Biogene., Danaher., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., PerkinElmer Inc. are some of the leading players operating in the Global Next Generation Sequencing Kits Market.

Report Scope

In this report, global Next Generation Sequencing Kits market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing Kits Market, By Workflow:

  • Library Preparation
  • Cluster Generation
  • Sequencing Reagents Kits

Next Generation Sequencing Kits Market, By Sequencing Type:

  • WES and WGS
  • Targeted Sequencing
  • Long Read Sequencing
  • Other Sequencing

Next Generation Sequencing Kits Market, By Usage Area:

  • Clinical
  • Research

Next Generation Sequencing Kits, By Application:

  • Oncology
  • Rare Diseases
  • Genetic Disorders
  • Reproductive Health
  • Others

Next Generation Sequencing Kits, By End User:

  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Others

Next Generation Sequencing Kits Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing Kits Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 5.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 5.2.3. By Usage Area (Clinical, Research)
    • 5.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 5.2.6. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.7. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Workflow
    • 5.3.2 By Sequencing Type
    • 5.3.3 By Usage Area
    • 5.3.4 By Application
    • 5.3.5 By End User
    • 5.3.6 By Region

6. North America Next Generation Sequencing Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 6.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 6.2.3. By Usage Area (Clinical, Research)
    • 6.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 6.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Workflow
        • 6.3.1.2.2. By Sequencing Type
        • 6.3.1.2.3. By Usage Area
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Next Generation Sequencing Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Workflow
        • 6.3.2.2.2. By Sequencing Type
        • 6.3.2.2.3. By Usage Area
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Next Generation Sequencing Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Workflow
        • 6.3.3.2.2. By Sequencing Type
        • 6.3.3.2.3. By Usage Area
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Next Generation Sequencing Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 7.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 7.2.3. By Usage Area (Clinical, Research)
    • 7.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 7.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Next Generation Sequencing Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Workflow
        • 7.3.1.2.2. By Sequencing Type
        • 7.3.1.2.3. By Usage Area
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Germany Next Generation Sequencing Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Workflow
        • 7.3.2.2.2. By Sequencing Type
        • 7.3.2.2.3. By Usage Area
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Workflow
        • 7.3.3.2.2. By Sequencing Type
        • 7.3.3.2.3. By Usage Area
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Next Generation Sequencing Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Workflow
        • 7.3.4.2.2. By Sequencing Type
        • 7.3.4.2.3. By Usage Area
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Next Generation Sequencing Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Workflow
        • 7.3.5.2.2. By Sequencing Type
        • 7.3.5.2.3. By Usage Area
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Next Generation Sequencing Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 8.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 8.2.3. By Usage Area (Clinical, Research)
    • 8.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 8.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Workflow
        • 8.3.1.2.2. By Sequencing Type
        • 8.3.1.2.3. By Usage Area
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Next Generation Sequencing Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Workflow
        • 8.3.2.2.2. By Sequencing Type
        • 8.3.2.2.3. By Usage Area
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Next Generation Sequencing Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Workflow
        • 8.3.3.2.2. By Sequencing Type
        • 8.3.3.2.3. By Usage Area
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Next Generation Sequencing Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Workflow
        • 8.3.4.2.2. By Sequencing Type
        • 8.3.4.2.3. By Usage Area
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Next Generation Sequencing Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Workflow
        • 8.3.5.2.2. By Sequencing Type
        • 8.3.5.2.3. By Usage Area
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Next Generation Sequencing Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 9.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 9.2.3. By Usage Area (Clinical, Research)
    • 9.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 9.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Workflow
        • 9.3.1.2.2. By Sequencing Type
        • 9.3.1.2.3. By Usage Area
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Next Generation Sequencing Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Workflow
        • 9.3.2.2.2. By Sequencing Type
        • 9.3.2.2.3. By Usage Area
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Next Generation Sequencing Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Workflow
        • 9.3.3.2.2. By Sequencing Type
        • 9.3.3.2.3. By Usage Area
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Next Generation Sequencing Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 10.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 10.2.3. By Usage Area (Clinical, Research)
    • 10.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 10.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Next Generation Sequencing Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Workflow
        • 10.3.1.2.2. By Sequencing Type
        • 10.3.1.2.3. By Usage Area
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Workflow
        • 10.3.2.2.2. By Sequencing Type
        • 10.3.2.2.3. By Usage Area
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Next Generation Sequencing Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Workflow
        • 10.3.3.2.2. By Sequencing Type
        • 10.3.3.2.3. By Usage Area
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1 Growing advancement in NGS
    • 11.1.2 Growing Demand for Early Detection of Chronic Diseases
  • 11.2. Challenges
    • 11.2.1 Lack of skilled professionals and infrastructure
    • 11.2.2 Stringent Regulations

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Next Generation Sequencing Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
    • 15.5.1. Agilent Technologies, Inc.
    • 15.5.2. Bio-Rad Laboratories, Inc.
    • 15.5.3. BGI Group.
    • 15.5.4. Creative Biogene
    • 15.5.5. Danaher.
    • 15.5.6. F. Hoffmann-La Roche Ltd.
    • 15.5.7. Hologic, Inc.
    • 15.5.8. Illumina, Inc.
    • 15.5.9. Oxford Nanopore Technologies plc.
    • 15.5.10. Pacific Biosciences of California, Inc.
    • 15.5.11. PerkinElmer Inc.

16. Strategic Recommendations